AENOVATION Trademark

Trademark Overview

On Thursday, December 19, 2024, a trademark application was filed for AENOVATION with the United States Patent and Trademark Office. The USPTO has given the AENOVATION trademark a serial number of 79416055. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Tuesday, June 10, 2025. This trademark is owned by Aenova Holding GmbH. The AENOVATION trademark is filed in the Treatment & Processing of Materials Services, Transportation & Storage Services, and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of pharmaceuticals

Packaging of goods

Product development for others; product development consultation; product development; pharmaceutical research services; inspection of pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; pharmaceutical products development; pharmaceutical product evaluation; laboratory research services relating to pharmaceuticals; development of pharmaceutical preparations and medicines; services for assessing the efficiency of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; research and development for the pharmaceutical industry; consultancy in the field of pharmaceutical research; consultancy services relating to product engineering; consultancy pertaining to pharmacology
aenovation

General Information

Serial Number79416055
Word MarkAENOVATION
Filing DateThursday, December 19, 2024
Status640 - NON-FINAL ACTION COUNTED - NOT MAILED
Status DateTuesday, June 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesCustom manufacture of pharmaceuticals
Goods and ServicesPackaging of goods
Goods and ServicesProduct development for others; product development consultation; product development; pharmaceutical research services; inspection of pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; pharmaceutical products development; pharmaceutical product evaluation; laboratory research services relating to pharmaceuticals; development of pharmaceutical preparations and medicines; services for assessing the efficiency of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; research and development for the pharmaceutical industry; consultancy in the field of pharmaceutical research; consultancy services relating to product engineering; consultancy pertaining to pharmacology

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, February 6, 2025
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class039 - Transport; packaging and storage of goods; travel arrangement.
US Class Codes100, 105
Class Status Code6 - Active
Class Status DateThursday, February 6, 2025
Primary Code039
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 6, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAenova Holding GmbH
Party Type10 - Original Applicant
Legal Entity Type98 - Unknown
AddressDE

Trademark Events

Event DateEvent Description
Thursday, February 6, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, February 7, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 7, 2025APPLICATION FILING RECEIPT MAILED
Thursday, June 5, 2025ASSIGNED TO EXAMINER
Tuesday, June 10, 2025NON-FINAL ACTION WRITTEN
Wednesday, June 11, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Related Keywords

aenovation pharmaceutical development research services product pharmaceuticals consultancy relating biotechnology efficiency